Rankings
▼
Calendar
FOLD Q4 2018 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
FOLD
Amicus Therapeutics, Inc.
$5B
Q4 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$33M
+121.6% YoY
Gross Profit
$28M
86.7% margin
Operating Income
-$69M
-212.9% margin
Net Income
-$78M
-239.2% margin
EPS (Diluted)
$-0.37
QoQ Revenue Growth
+58.5%
Cash Flow
Operating Cash Flow
-$61M
Free Cash Flow
-$62M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$790M
Total Liabilities
$447M
Stockholders' Equity
$343M
Cash & Equivalents
$80M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$33M
$15M
+121.6%
Gross Profit
$28M
$12M
+133.5%
Operating Income
-$69M
-$68M
-2.7%
Net Income
-$78M
-$69M
-12.8%
← FY 2018
All Quarters
Q1 2019 →